ÂÜÀòÂÒÂ×

Mr. David Maris is a private investor with Phalanx Investment Partners, LLC, an investment advisor, since January 2020, and a member of the board of directors of Amphastar Pharmaceuticals (NASDAQ: AMPH) since 2020, where he also serves on the audit committee. From December 2015 to December 2019, Mr. David Maris was a managing director and equity research analyst at Wells Fargo Securities, LLC, an investment bank. Before serving at Wells Fargo Securities, LLC, Mr. David Maris served as a managing director and equity research analyst at Bank of Montreal, an investment bank, from January 2013 to December 2015. Prior to serving Bank of Montreal and Wells Fargo Securities, LLC, Mr. David Maris served as a healthcare industry equity analyst for several other investment banks, including Credit Agricole – CLSA, Bank of America, Credit Suisse, Bear Stearns, and Aros Securities. He also served as a healthcare portfolio manager for Balaysny Asset Management and currently serves as a member of the American Finance Association and National Association of Corporate Directors.

Mr. David Maris holds a B.A. from the University of Delaware and an M.B.A. from Vanderbilt University’s Owen Graduate School of Management.